Lilly Partners with Area Health Systems to Help Enable Access to Important Antibody Infusion Therapies for COVID-19 Patients
"Throughout the implementation of our COVID-19 antibody clinical development program, we have identified multiple approaches to address many of the challenges this virus has presented, including complexities experienced with intravenous administration during the pandemic," said
The opening of these infusion centers provides additional dedicated locations in which people can receive COVID-19 infusion treatments. Last week
"We're thankful for the opportunity to collaborate with our health system partners and
The establishment of these infusion centers has provided needed treatment options and it has offered an opportunity to find creative solutions to eliminating treatment barriers.
Patients should contact their physician to see if a COVID-19 antibody treatment is right for them. To learn more about these and other COVID-19 antibody infusion site locations across
COVID-19 Infusion Center Locations:
Northern Indiana: COVID Infusion Center 60205 Bodnar Blvd. Mishawaka, IN46544 Central Indiana: Neurodiagnostic Center 5435 East 16th Street, 4th floor, Indianapolis, IN46218 Southern Indiana: Ascension St.Vincent Evansville 100 St Mary's Epworth Crossing Newburgh Evansville IN 47630
About Lilly's COVID-19 Efforts
Lilly is bringing the full force of its scientific and medical expertise to attack the coronavirus pandemic around the world. Existing Lilly medicines are being studied to understand their potential in treating complications of COVID-19, and the company is collaborating with partner companies to discover novel antibody treatments for COVID-19. Lilly is testing both single antibody therapy as well as multiple antibodies used together as potential therapeutics for COVID-19. Click here for resources related to Lilly's COVID-19 efforts.
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and www.lilly.com/news.
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about intravenous administration of antibody therapies for the treatment of patients with or at risk of infection from COVID-19,
Kevin Hern; firstname.lastname@example.org; 317-277-1838 (Investor Relations)
View original content to download multimedia:http://www.prnewswire.com/news-releases/lilly-partners-with-area-health-systems-to-help-enable-access-to-important-antibody-infusion-therapies-for-covid-19-patients-301218598.html